Navigating Childhood Disorders- An Annotated Bibliography of Current Research
Anxiety disorders remain one of the most common psychiatric illnesses among children and adolescents. Traditionally thought to be benign, these disorders are disruptive, often affecting the social, academic, and family functioning of the affected child or teen. People with anxiety often suffer from low self-esteem. This disorder also remains a modifiable risk factor for other medical problems such as depression, heart disease, and diabetes, among others. This paper annotates three sources on anxiety centered on the thematic concerns of management and the epidemiology of anxiety disorders.
Anxiety Disorders in Children and Adolescents
Racine, N., McArthur, B. A., Cooke, J. E., Eirich, R., Zhu, J., & Madigan, S. (2021). Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19. JAMA Pediatrics, 175(11), 1142. https://doi.org/10.1001/jamapediatrics.2021.2482
This article is centered on childhood and adolescent anxiety. It explores the global prevalence of clinically relevant anxiety and depression among children and adolescents and whether the demographic parameters of age, sex, and geographical location are factors in the variation of the prevalence rates. According to the author, the recent COVID pandemic led to dramatic disruptions in the way of life of communities across the globe. Some of these disruptions were evident in the health and wellness of these communities, with some demonstrating particularly higher variance in the incidence of various illnesses.
As per the author’s findings, the global prevalence of anxiety and depression among children and adolescents increased compared to pre-pandemic levels. The implications of the increased prevalence of these illnesses are expected to be felt in healthcare systems across the globe. The author forecasts an influx in the utilization of mental healthcare resources in the years after the pandemic. Increasing the allocation of resources to mental healthcare may help guarantee healthier communities in the wake of the growing prevalence of anxiety and depressive disorders among children and adolescents.
This article is a meta-analysis seeking to ascertain the precise estimates of the prevalence of anxiety and depression among children and adolescents across the globe. Findings from the article show the global position on mental healthcare by detailing the impact of the recent pandemic on the prevalence of anxiety and depression. It also demonstrates the implications of the growing prevalence of anxiety and depression on mental healthcare resources. These findings can be used to inform quality enhancement in mental healthcare. By ascertaining the prevalence of these illnesses, healthcare systems across the globe are better positioned to respond to any variations, thereby enabling the continuity of quality care.
Walter, H. J., Bukstein, O. G., Abright, A. R., Keable, H., Ramtekkar, U., Ripperger-Suhler, J., & Rockhill, C. (2020). Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 59(10), 1107–1124. https://doi.org/10.1016/j.jaac.2020.05.005
This article is based on the comprehensive management of anxiety disorders. It details the clinical practice guidelines for the management of anxiety disorders in children and adolescents. According to the author, anxiety disorders are common presentations in children and adolescents. Comprehensive management of these disorders requires accurate diagnosis and distinction of the anxiety type involved, as well as the observance of best practices when managing these illnesses. Diagnostic evaluation is the first step in managing these disorders. A combination of subjective and objective findings and findings from various screening tools and the DSM-V manual is necessary for the accurate diagnosis of anxiety disorders.
As per the findings, a combination of psychotherapy and pharmacotherapy is utilizable in managing anxiety disorders. Empirical findings support the use of selective serotonin reuptake inhibitors and cognitive behavioral therapy in the management of anxiety disorders. These modalities are safe and effective in alleviating anxiety symptoms. Selective norepinephrine reuptake inhibitors are effective alternatives to SSRIs.
This article is a mixed-method paper employing systematic reviews and expert options. Therapeutic modalities recommended by the author are based on systematic review articles on the management of anxiety disorders. This article gives a systematic guide used in managing anxiety disorders. It highlights safe and effective therapeutic modalities utilizable in the pediatric and adolescent population. In the pursuit of quality mental healthcar